Is Zealand Pharma A/S halal to invest in?

As of October 2026, Zealand Pharma A/S ZEAL.CO is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Zealand Pharma A/S a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Zealand Pharma A/S using these criteria to determine its compliance status.

Can Muslims buy shares of Zealand Pharma A/S?

Muslim investors may consider investing in Zealand Pharma A/S if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Zealand Pharma A/S classified as NOT HALAL?

Musaffa determines the Shariah status of Zealand Pharma A/S by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Zealand Pharma A/S updated?

The Shariah compliance status of Zealand Pharma A/S may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Zealand Pharma A/S become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Zealand Pharma A/S?

You can check the latest Shariah compliance status of Zealand Pharma A/S on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Is Zealand Pharma A/S Stock Halal?

Shariah Compliance Analysis of ZEAL.CO Stock

Denmark Health Care Mid Cap

No. As of October 2026, Zealand Pharma A/S (ZEAL.CO) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Zealand Pharma A/S does not pass Musaffa's business and financial screening criteria.

Zealand Pharma A/S is a biotechnology company, which engages in the discovery, design, and development of peptide based medicines. The firm is focused on the discovery, design and development of peptide-based medicines for metabolic and gastrointestinal diseases and other rare disease areas with unmet medical needs. The firm's peptide-based product candidates includes clinical development, registration and, potentially, commercialization. Its pipeline includes three product candidates in clinical development: glepaglutide, which is being developed to treat short bowel syndrome, or SBS; dasiglucagon formulated for use in a dual-hormone artificial pancreas system for better diabetes management; and dasiglucagon for use in the treatment of congenital hyperinsulinism. The firm operates in Denmark and the USA and has a portfolio of medicines and product candidates, including collaborations with Boehringer Ingelheim.

Zealand Pharma A/S ZEAL.CO

Last Updated: Oct 09, 12:00 AM·CSE

ZEAL.CO Shariah Compliance

Screening Methodology: AAOIFI

As of October 2026, Zealand Pharma A/S is classified as not halal.

NOT HALAL